source
- HHS permits compounding of six experimental peptides despite FDA scientists' safety concernsHHS issued a temporary policy that lets licensed pharmacies and physicians compound six experimental peptides without risk of federal enforcement. The list includes the injury-recovery duo BPC-157…
- HHS issues temporary policy permitting compounding pharmacies to produce certain peptide drugsThe U.S. Department of Health and Human Services announced a new policy that temporarily authorizes compounding pharmacies to manufacture specific peptide products that are not otherwise commercial…